Bloomberg Law
April 16, 2020, 7:09 PM

FDA Relaxes Rules to Make Muscle Relaxers, Drugs for Covid-19

Jacquie Lee
Jacquie Lee

Hospitals will have more options to buy drugs used to treat Covid-19 patients—like muscle relaxers and painkillers—thanks to relaxed rules the FDA announced Thursday to address drug shortages across the country.

The changes mean facilities that produce drugs and sell them to hospitals don’t have to stick to a strict ingredient list established by the FDA when making large batches of drugs for hospitals to treat Covid-19 patients.

They are also freed from some manufacturing steps that would otherwise be typically required, such as running tests to determine expiration dates or abiding by certain packaging restrictions.

The rules apply to ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.